SunLink Health [SSY] vs Scienture Holdings [SCNX] Detailed Stock Comparison
SunLink Health
NYSE
Loading...
Scienture Holdings
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: SunLink Health wins in 11 metrics, Scienture Holdings wins in 5 metrics, with 0 ties. SunLink Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | SunLink Health | Scienture Holdings | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.07 | 1.70 | SunLink Health |
| Price-to-Book Ratio | 0.59 | 0.18 | Scienture Holdings |
| Debt-to-Equity Ratio | 4.98 | 5.30 | SunLink Health |
| PEG Ratio | 0.10 | -0.03 | Scienture Holdings |
| EV/EBITDA | -0.46 | -1.10 | Scienture Holdings |
| Profit Margin (TTM) | 5.55% | 4.39% | SunLink Health |
| Operating Margin (TTM) | -9.33% | -12,824.74% | SunLink Health |
| Return on Equity | -22.34% | -54.26% | SunLink Health |
| Return on Assets (TTM) | -13.62% | -19.67% | SunLink Health |
| Free Cash Flow (TTM) | $-4.45M | $-14.27M | SunLink Health |
| Dividend Yield | N/A | 151.52% | N/A |
| 1-Year Return | 33.33% | -87.62% | SunLink Health |
| Price-to-Sales Ratio (TTM) | 0.25 | 142.78 | SunLink Health |
| Enterprise Value | $1.05M | $18.08M | Scienture Holdings |
| EV/Revenue Ratio | 0.03 | 141.04 | SunLink Health |
| Gross Profit Margin (TTM) | 37.14% | N/A | N/A |
| Revenue per Share (TTM) | $4 | $0 | SunLink Health |
| Earnings per Share (Diluted) | $-0.39 | $0.51 | Scienture Holdings |
| Beta (Stock Volatility) | 1.15 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
SunLink Health vs Scienture Holdings Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| SunLink Health | 16.15% | 3.70% | 15.46% | 33.33% | 16.67% | 23.08% |
| Scienture Holdings | -2.70% | 2.35% | -10.31% | -40.00% | -16.35% | -85.50% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| SunLink Health | 33.33% | -5.88% | 12.00% | -34.88% | -45.10% | -86.95% |
| Scienture Holdings | -87.62% | -94.53% | -99.04% | -90.33% | -96.13% | -96.13% |
Performance & Financial Health Analysis: SunLink Health vs Scienture Holdings
| Metric | SSY | SCNX |
|---|---|---|
| Market Information | ||
| Market Cap | $6.97M | $18.30M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 246,965 | 152,125 |
| 90 Day Avg. Volume | 239,518 | 362,002 |
| Last Close | $1.12 | $0.84 |
| 52 Week Range | $0.62 - $1.91 | $0.69 - $9.55 |
| % from 52W High | -41.62% | -91.18% |
| All-Time High | $21.00 (Jun 09, 1986) | $174.00 (Mar 23, 2020) |
| % from All-Time High | -94.67% | -99.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | -1.00% |
| Quarterly Earnings Growth | -0.02% | -1.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.04% |
| Operating Margin (TTM) | -0.09% | -128.25% |
| Return on Equity (TTM) | -0.22% | -0.54% |
| Debt to Equity (MRQ) | 4.98 | 5.30 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.91 | $4.83 |
| Cash per Share (MRQ) | $1.06 | $0.00 |
| Operating Cash Flow (TTM) | $-2,929,000 | $-13,288,225 |
| Levered Free Cash Flow (TTM) | $1.48M | $-2,928,467 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 151.52% |
| Last 12-Month Dividend | $0.00 | $1.50 |
Valuation & Enterprise Metrics Analysis: SunLink Health vs Scienture Holdings
| Metric | SSY | SCNX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.07 | 1.70 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.10 | -0.03 |
| Price to Sales (TTM) | 0.25 | 142.78 |
| Price to Book (MRQ) | 0.59 | 0.18 |
| Market Capitalization | ||
| Market Capitalization | $6.97M | $18.30M |
| Enterprise Value | $1.05M | $18.08M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.03 | 141.04 |
| Enterprise to EBITDA | -0.46 | -1.10 |
| Risk & Other Metrics | ||
| Beta | 1.15 | N/A |
| Book Value per Share (MRQ) | $1.91 | $4.83 |
Financial Statements Comparison: SunLink Health vs Scienture Holdings
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SSY | SCNX |
|---|---|---|
| Revenue/Sales | $7.32M | $10,258 |
| Cost of Goods Sold | $4.60M | $9,585 |
| Gross Profit | $2.72M | $673 |
| Research & Development | N/A | $574,679 |
| Operating Income (EBIT) | $-683,000 | $-3.57M |
| EBITDA | $-350,000 | $-3.63M |
| Pre-Tax Income | $-630,000 | $-3.06M |
| Income Tax | $0 | $0 |
| Net Income (Profit) | $-671,000 | $-3.06M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SSY | SCNX |
|---|---|---|
| Cash & Equivalents | $7.47M | $2.05M |
| Total Current Assets | $13.71M | $7.83M |
| Total Current Liabilities | $3.50M | $7.46M |
| Long-Term Debt | $388,000 | $1.23M |
| Total Shareholders Equity | $13.41M | $81.16M |
| Retained Earnings | $-1.09M | $-42.10M |
| Property, Plant & Equipment | $11.71M | $203,909 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SSY | SCNX |
|---|---|---|
| Operating Cash Flow | N/A | $-1.39M |
| Capital Expenditures | $100,000 | N/A |
| Free Cash Flow | $-654,000 | $-2.96M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SSY | SCNX |
|---|---|---|
| Shares Short | 10,601 | 212,625 |
| Short Ratio | 0.05 | 0.71 |
| Short % of Float | 0.00% | 0.02% |
| Average Daily Volume (10 Day) | 246,965 | 152,125 |
| Average Daily Volume (90 Day) | 239,518 | 362,002 |
| Shares Outstanding | 7.04M | 8.75M |
| Float Shares | 4.66M | 12.81M |
| % Held by Insiders | 0.28% | 0.25% |
| % Held by Institutions | 0.15% | 0.01% |
Dividend Analysis & Yield Comparison: SunLink Health vs Scienture Holdings
| Metric | SSY | SCNX |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $1.50 |
| Last 12-Month Dividend Yield | N/A | 151.52% |
| 3-Year Avg Annual Dividend | $0.00 | $3.17 |
| 3-Year Avg Dividend Yield | N/A | 44.93% |
| 3-Year Total Dividends | $0.00 | $9.50 |
| Ex-Dividend Date | N/A | Jul 19, 2024 |